| Bioactivity | Cap-dependent endonuclease-IN-3 is a potent inhibitor of cap-dependent endonuclease (CEN). Not only can Cap-dependent endonuclease-IN-3 inhibit influenza virus well, but also has lower cytotoxicity, better in vivo agent kinetic properties and in vivo pharmacodynamic properties. Cap-dependent endonuclease-IN-3 has the potential for the research of influenza A and influenza B infection (extracted from patent WO2019141179A1, compound VI-1)[1]. |
| Name | Cap-dependent endonuclease-IN-3 |
| CAS | 2364589-86-4 |
| Formula | C29H25F2N3O7S |
| Molar Mass | 597.59 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Li Chen, et al. Pyridone derivative, its composition and application as anti-influenza virus drug. Patent WO2019141179A1. |
Cap-dependent endonuclease-IN-3
CAS: 2364589-86-4 F: C29H25F2N3O7S W: 597.59
Cap-dependent endonuclease-IN-3 is a potent inhibitor of cap-dependent endonuclease (CEN). Not only can Cap-dependent en
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.